{
    "Trade/Device Name(s)": [
        "ZEUS ELISA Treponema pallidum IgG Test System",
        "Treponema pallidum IgG ELISA Test System"
    ],
    "Submitter Information": "Zeus Scientific, Inc.",
    "510(k) Number": "K102283",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "January 25, 2011",
    "Summary Letter Received Date": "January 26, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Treponema pallidum IgG antibody"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme linked immunosorbent assay (ELISA)",
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ZEUS ELISA Treponema pallidum IgG Test System for qualitative detection of T. pallidum IgG antibodies in human serum via ELISA",
    "Indications for Use Summary": "Qualitative detection of specific IgG antibodies to Treponema pallidum in human serum, providing serological evidence of infection in conjunction with non-treponemal assays and clinical findings; not intended for blood or plasma donor screening",
    "fda_folder": "Microbiology"
}